NM_000251.3(MSH2):c.2090G>A (p.Cys697Tyr) AND Hereditary nonpolyposis colorectal neoplasms

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 8, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000817438.7

Allele description [Variation Report for NM_000251.3(MSH2):c.2090G>A (p.Cys697Tyr)]

NM_000251.3(MSH2):c.2090G>A (p.Cys697Tyr)

Gene:
MSH2:mutS homolog 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NM_000251.3(MSH2):c.2090G>A (p.Cys697Tyr)
HGVS:
  • NC_000002.12:g.47476451G>A
  • NG_007110.2:g.78328G>A
  • NM_000251.3:c.2090G>AMANE SELECT
  • NM_001258281.1:c.1892G>A
  • NP_000242.1:p.Cys697Tyr
  • NP_000242.1:p.Cys697Tyr
  • NP_001245210.1:p.Cys631Tyr
  • LRG_218t1:c.2090G>A
  • LRG_218:g.78328G>A
  • LRG_218p1:p.Cys697Tyr
  • NC_000002.11:g.47703590G>A
  • NM_000251.1:c.2090G>A
  • NM_000251.2:c.2090G>A
  • c.2090G>A
  • p.C697Y
Protein change:
C631Y
Links:
dbSNP: rs63750398
NCBI 1000 Genomes Browser:
rs63750398
Molecular consequence:
  • NM_000251.3:c.2090G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258281.1:c.1892G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary nonpolyposis colorectal neoplasms
Identifiers:
MeSH: D003123; MedGen: C0009405

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000957998Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jul 8, 2023)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.

Espenschied CR, LaDuca H, Li S, McFarland R, Gau CL, Hampel H.

J Clin Oncol. 2017 Aug 1;35(22):2568-2575. doi: 10.1200/JCO.2016.71.9260. Epub 2017 May 17.

PubMed [citation]
PMID:
28514183
PMCID:
PMC7186580

Endoscopic full thickness resection for early colon cancer in Lynch syndrome.

Langers AMJ, Boonstra JJ, Hardwick JCH, van der Kraan J, Farina Sarasqueta A, Vasen HFA.

Fam Cancer. 2019 Jul;18(3):349-352. doi: 10.1007/s10689-019-00132-w.

PubMed [citation]
PMID:
31111311
PMCID:
PMC6559999
See all PubMed Citations (10)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000957998.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 697 of the MSH2 protein (p.Cys697Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with pancreatic cancer and urothelial carcinoma, as well as an individual undergoing genetic testing for Lynch syndrome (PMID: 28514183, 31111311). ClinVar contains an entry for this variant (Variation ID: 187518). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 33357406) indicates that this missense variant is expected to disrupt MSH2 function. Experimental studies have shown that this missense change affects MSH2 function (PMID: 6951660). This variant disrupts the p.Cys697 amino acid residue in MSH2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9298827, 16327991, 17101317, 18951462, 22102614). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024